Download
s00228-021-03090-4.pdf 2,22MB
WeightNameValue
1000 Titel
  • Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review
1000 Autor/in
  1. Sierocinski, Elizabeth |
  2. Holzinger, Felix |
  3. Chenot, Jean-François |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-01
1000 Erschienen in
1000 Quellenangabe
  • 77(8):1113-1122
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00228-021-03090-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275562/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!Acute cough due to viral upper respiratory tract infections (URTIs) and bronchitis is a common reason for patients to seek medical care. Non-antibiotic over-the-counter cough medications such as ivy leaf extract are frequently used but their efficacy is uncertain. Our purpose was to update our previous systematic review and evaluate the effectiveness and tolerability of ivy leaf in the treatment of acute URTIs in adult and pediatric populations.!##!Methods!#!We searched MEDLINE, EMBASE, the Cochrane Library, and clinical trial registries from December 2009 to January 2020. Randomized controlled trials (RCTs), controlled clinical trials (CCTs), and observational studies (OSs) investigating ivy leaf mono- or combination preparations were included. Two independent reviewers assessed records for eligibility and risk of bias and performed data extraction.!##!Results!#!Six RCTs, 1 CCT, and 4 OSs were identified. Since the publication of our previous review, the number of RCTs has increased. All studies concluded that ivy leaf extract is an effective and safe option for the treatment of cough due to URTIs and bronchitis. Three RCTs reported a more rapid reduction in cough severity and/or frequency under ivy leaf treatment. The clinical significance of these effects appears to be minimal. No serious adverse effects were reported. The overall quality of reporting was low and the risk of bias was high.!##!Conclusions!#!Ivy leaf preparations are safe for use in cough due to acute URTIs and bronchitis. However, effects are minimal at best and of uncertain clinical importance.
1000 Sacherschließung
lokal
lokal Plant Extracts/therapeutic use [MeSH]
lokal Bronchitis
lokal Humans [MeSH]
lokal Ivy leaf extract
lokal Hedera [MeSH]
lokal Patient Acuity [MeSH]
lokal Quality of Life [MeSH]
lokal Cough/drug therapy [MeSH]
lokal Plant Leaves [MeSH]
lokal Review
lokal Drug Compounding [MeSH]
lokal Plant Extracts/administration
lokal Plant Extracts/adverse effects [MeSH]
lokal Acute cough
lokal Respiratory Tract Infections/drug therapy [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3679-671X|https://orcid.org/0000-0002-8400-7757|https://orcid.org/0000-0001-8877-2950
1000 Hinweis
  • DeepGreen-ID: 3ac3c574a0bd48a3bc79f4abe3895c3f ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6451593.rdf
1000 Erstellt am 2023-05-11T14:05:52.836+0200
1000 Erstellt von 322
1000 beschreibt frl:6451593
1000 Zuletzt bearbeitet 2023-10-24T07:43:41.479+0200
1000 Objekt bearb. Tue Oct 24 07:43:41 CEST 2023
1000 Vgl. frl:6451593
1000 Oai Id
  1. oai:frl.publisso.de:frl:6451593 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source